NasdaqGS - Delayed Quote USD
Alkermes plc (ALKS)
27.84
+0.17
+(0.61%)
At close: April 25 at 4:00:02 PM EDT
27.84
0.00
(0.00%)
After hours: April 25 at 4:27:16 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| ALVA EMILY PETERSON Director | Conversion of Exercise of derivative security | Jun 28, 2024 | 27,302 |
| BROWN IAIN MICHAEL Chief Financial Officer | Conversion of Exercise of derivative security | Feb 26, 2025 | 148,196 |
| GAFFIN DAVID JOSEPH Officer | Conversion of Exercise of derivative security | Feb 26, 2025 | 204,255 |
| HOPKINSON CRAIG C Officer | Conversion of Exercise of derivative security | Feb 26, 2025 | 77,740 |
| JACKSON BLAIR CURTIS Chief Operating Officer | Conversion of Exercise of derivative security | Feb 26, 2025 | 201,368 |
| LAURENCIN CATO T Director | Conversion of Exercise of derivative security | Dec 9, 2024 | 23,013 |
| LURKER NANCY S Director | Conversion of Exercise of derivative security | Apr 11, 2025 | 4,616 |
| NICHOLS CHRISTIAN TODD Officer | Conversion of Exercise of derivative security | Feb 26, 2025 | 92,875 |
| PARISI SAMUEL JOSEPH Officer | Sale | Feb 28, 2025 | 7,717 |
| POPS RICHARD F Chief Executive Officer | Stock Award(Grant) | Feb 6, 2025 | 1,290,390 |
Related Tickers
NBIX Neurocrine Biosciences, Inc.
106.73
+0.92%
PCRX Pacira BioSciences, Inc.
25.72
-1.08%
COLL Collegium Pharmaceutical, Inc.
26.79
+0.04%
DVAX Dynavax Technologies Corporation
10.82
-0.73%
IPSEY Ipsen S.A.
27.90
0.00%
EGRX Eagle Pharmaceuticals, Inc.
1.7000
-13.71%
TAK Takeda Pharmaceutical Company Limited
15.03
-0.53%
UTHR United Therapeutics Corporation
291.38
-1.70%
SUPN Supernus Pharmaceuticals, Inc.
32.22
+2.78%
YCBD cbdMD, Inc.
0.2629
+3.10%